Health Risks Grow as Young People Born With HIV Age
Anne M. Neilan, M.D., MPH, Fellow, Infectious Diseases, Massachusetts General Hospital, Boston
Teens and young adults who were infected with HIV near the time of birth are at increased risk for serious health problems and death, a new study finds.
Read more: Health Risks Grow as Young People Born With HIV Age
Hepatitis C Drug's Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment
HIV new diagnosis rate is down.
Valerie Green is still waiting to be cured. The Delaware resident was diagnosed with hepatitis C more than two years ago, but she doesn't qualify yet for the Medicaid program's criteria for treatment with a new class of highly effective but pricey drugs.
Read more: Hepatitis C Drug's Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment
Hepatitis Infection May Raise Risk for Parkinson's Disease
Michael S. Okun, M.D., Chair, Department of Neurology, College of Medicine, University of Florida, and National Medical Director, Parkinson's Foundation
People with the liver infection hepatitis may be at heightened risk of developing Parkinson's disease, a large new study suggests.
The study, published online March 29 in Neurology, is the second in the past year to link hepatitis to Parkinson's.
Read more: Hepatitis Infection May Raise Risk for Parkinson's Disease
Heroes in the Struggle: Laverne Cox
Laverne Cox
The Black AIDS Institute's Heroes in the Struggle Gala and Award Celebration honors, in a star-studded event and photographic tribute, individuals who, over the past year, have made a heroic contribution to the fight against HIV/AIDS.
Highlights from First Day of CROI 2017
Anne Rancourt, Communications Section Chief, at NIH's NIAID chats with Carl W. Dieffenbach, Ph.D., the Director of the Division of AIDS at NIH's National Institute of Allergy and Infectious Diseases, on information provided on the first day of the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle
We reported from the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle sharing news and information about some of the important new HIV research findings and data being released. After the first full day of sessions, we held two Facebook Live sessions with senior federal HIV leaders to hear about what they saw as some of the key science highlights of the day.